Knight Therapeutics Stock Price on June 12, 2023
KHTRF Stock | USD 3.75 0.04 1.06% |
If you're considering investing in Knight Pink Sheet, it is important to understand the factors that can impact its price. As of today, the current price of Knight Therapeutics stands at 3.75, as last reported on the 11th of December 2024, with the highest price reaching 3.75 and the lowest price hitting 3.75 during the day. Knight Therapeutics has Sharpe Ratio of -0.19, which conveys that the firm had a -0.19% return per unit of risk over the last 3 months. Knight Therapeutics exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Knight Therapeutics' Standard Deviation of 1.59, risk adjusted performance of (0.06), and Mean Deviation of 0.7969 to check out the risk estimate we provide.
Knight Pink Sheet price history is provided at the adjusted basis, taking into account all of the recent filings.
Knight |
Sharpe Ratio = -0.1864
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | KHTRF |
Estimated Market Risk
1.35 actual daily | 12 88% of assets are more volatile |
Expected Return
-0.25 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.19 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Knight Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Knight Therapeutics by adding Knight Therapeutics to a well-diversified portfolio.
Knight Therapeutics Valuation on June 12, 2023
It is possible to determine the worth of Knight Therapeutics on a given historical date. On June 12, 2023 Knight was worth 3.68 at the beginning of the trading date compared to the closed value of 3.68. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Knight Therapeutics pink sheet. Still, in general, we apply an absolute valuation method to find Knight Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Knight Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Knight Therapeutics' related companies.
Open | High | Low | Close | Volume | |
3.68 | 3.68 | 3.68 | 3.68 | 1.00 | |
06/12/2023 | 3.68 | 3.68 | 3.68 | 3.68 | 1.00 |
3.71 | 3.72 | 3.71 | 3.72 | 24,000 |
Backtest Knight Therapeutics | | | Knight Therapeutics History | | | Knight Therapeutics Valuation | Previous | Next |
Knight Therapeutics Trading Date Momentum on June 12, 2023
On June 13 2023 Knight Therapeutics was traded for 3.72 at the closing time. The highest daily price throughout the period was 3.72 and the lowest price was 3.71 . The daily volume was 24 K. The net trading volume on 06/13/2023 added to the next day price rise. The trading delta at closing time to closing price of the next trading day was 1.09% . The trading delta at closing time to current closing price is 1.36% . |
Knight Therapeutics Fundamentals Correlations and Trends
By evaluating Knight Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Knight Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Knight financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Knight Therapeutics Pink Sheet history
Knight Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Knight is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Knight Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Knight Therapeutics stock prices may prove useful in developing a viable investing in Knight Therapeutics
Knight Therapeutics Inc., a specialty pharmaceutical company, develops, acquires, in-licenses, out-licenses, markets, and distributes pharmaceutical and consumer health products, and medical devices in Canada, Latin America, and internationally. Knight Therapeutics Inc. was incorporated in 2013 and is headquartered in Montreal, Canada. Knight Therapeutics operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 660 people.
Knight Therapeutics Pink Sheet Technical Analysis
Knight Therapeutics technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
Price Boundaries
Knight Therapeutics Period Price Range
Low | December 11, 2024
| High |
0.00 | 0.00 |
Knight Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on PINK Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Knight Therapeutics December 11, 2024 Market Strength
Market strength indicators help investors to evaluate how Knight Therapeutics pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Knight Therapeutics shares will generate the highest return on investment. By undertsting and applying Knight Therapeutics pink sheet market strength indicators, traders can identify Knight Therapeutics entry and exit signals to maximize returns
Knight Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Knight Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Knight Pink Sheet historical price patterns, it is also worthwhile for investors to track various predictive indicators of Knight to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.06) | |||
Jensen Alpha | (0.14) | |||
Total Risk Alpha | (0.40) | |||
Treynor Ratio | 2.37 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Complementary Tools for Knight Pink Sheet analysis
When running Knight Therapeutics' price analysis, check to measure Knight Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Knight Therapeutics is operating at the current time. Most of Knight Therapeutics' value examination focuses on studying past and present price action to predict the probability of Knight Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Knight Therapeutics' price. Additionally, you may evaluate how the addition of Knight Therapeutics to your portfolios can decrease your overall portfolio volatility.
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
CEOs Directory Screen CEOs from public companies around the world | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation |